Nathan Caffo

Nathan Caffo has held various executive roles in the biotechnology and pharmaceutical industry, including CEO, President, CBO, Board Member, and Strategic Advisor. Nathan has experience working in companies focused on oncology therapeutics, genomic diagnostics, and business development. Caffo's career highlights include leadership positions at Stealth Oncology Therapeutics, Candel Therapeutics, ALX Oncology, and Presage Biosciences. Additionally, Nathan has held roles at companies such as Curidium Medica, Perlegen Sciences, Applied Biosystems, and Celera.